Clinical utility of the prostate cancer gene 3 ( <scp>PCA</scp> 3) urine assay in <scp>J</scp> apanese men undergoing prostate biopsy

Abstract

The PCA3 score was significantly superior to f/t PSA in predicting a positive biopsy result for prostate cancer in Japanese men with PSA 4-10 ng/mL. The combination of PSAD and PCA3 score may be useful for selecting patients who could avoid an unnecessary biopsy.